4
Changes in Ownership
Olema Oncology, Inc. Filed Acc 0001415889-24-029028
Director sold 16,393 shares at an average $9.03 ($147,956)
- Director acquired 29,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harmon Cyrus Director | 2024-12-09 | Grant or award | +29,250 | 780,533 | D | ||
| Harmon Cyrus Director | 2024-12-10 | Sale | −8,256 | $9.37 | $77,359 | 772,277 | D |
| Harmon Cyrus Director | 2024-12-11 | Sale | −7,958 | $8.66 | $68,916 | 764,319 | D |
| Harmon Cyrus Director | 2024-12-11 | Sale | −179 | $9.39 | $1,681 | 764,140 | D |
| Open-market sales · 16,393 sh · avg $9.03 · $147,956 | |||||||
Loading xslF345X05/form4-12122024_121240.xml…